Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endocrine Gland Neoplasms × Psilocybin × Sarcoma × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Lymphoid 1 Dermatologic 1

Conditions

Osteosarcoma 1 Melanoma 1 Lymphoma 1 Endocrine Gland Neoplasms 1

Interventions

temsirolimus 1 selpercatinib 1 repotrectinib 1 Valproic Acid 1 Sirolimus 1 Psilocybin 1 Immunoglobulin G 1 Etoposide 1 Disulfides 1 Cyclophosphamide 1 Cetuximab 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06416085 2026-03-05

Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer

University Health Network, Toronto

Phase 2 Active not recruiting

DermatologicLymphoidSarcoma

Endocrine Gland Neoplasms, Lymphoma, Melanoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡